Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22341413 | 0.85 | ALDH1A1 (0.43) | ALDH1A1L3MBTL1 | |
| SCHEMBL17030340 | 0.78 | ALDH1A1 (0.44) | ALDH1A1L3MBTL1 | |
| SCHEMBL14737887 | 0.76 | ALDH1A1 (0.42) | ALDH1A1L3MBTL1 | |
| SCHEMBL18918047 | 0.76 | ALDH1A1 (0.36) | ALDH1A1L3MBTL1 | |
| SCHEMBL1853215 | 0.76 | ALDH1A1 (0.38) | ALDH1A1L3MBTL1 | |
| SCHEMBL6185698 | 0.76 | ALDH1A1 (0.48) | ALDH1A1L3MBTL1 | |
| SCHEMBL27848826 | 0.76 | ALDH1A1 (0.44) | ALDH1A1 | |
| SCHEMBL12852874 | 0.73 | MEN1 (0.36) | ALDH1A1L3MBTL1 | |
| SCHEMBL3246663 | 0.73 | ALDH1A1 (0.36) | ALDH1A1L3MBTL1 | |
| SCHEMBL12852872 | 0.73 | ALDH1A1 (0.33) | ALDH1A1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250197420-A1 | MACROCYCLIC COMPOUNDS, COMPOSITIONS, AND METHODS OF USING THEREOF | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2025-06-19 | — | — | US | disclosed |
| EP-2341886-B1 | ANTIMICROBIAL N-CHLORINATED COMPOSITIONS | NOVABAY PHARMACEUTICALS INC (US) | 2015-08-26 | — | — | EP | disclosed |
| US-8278482-B2 | Antimicrobial N-chlorinated compositions | NOVABAY PHARMACEUTICALS, INC. (US) | 2012-10-02 | — | — | US | disclosed |
| US-8278482-B2 | Antimicrobial N-chlorinated compositions | NOVABAY PHARMACEUTICALS, INC. (US) | 2012-10-02 | — | — | US | disclosed |
| US-8278482-B2 | Antimicrobial N-chlorinated compositions | NOVABAY PHARMACEUTICALS, INC. (US) | 2012-10-02 | — | — | US | disclosed |
| EP-2341886-A1 | ANTIMICROBIAL N-CHLORINATED COMPOSITIONS | NovaBay Pharmaceuticals, Inc. (US) | 2011-07-13 | — | — | EP | disclosed |
| US-7939658-B2 | Enantiomeric pure beta agonists, manufacturing and use as a medicaments thereof | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2011-05-10 | — | — | US | disclosed |
| US-20100297028-A1 | MEDICAMENT COMBINATIONS FOR THE TREATMENT OF RESPIRATORY DISEASES | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2010-11-25 | — | — | US | disclosed |
| US-20100158818-A1 | ANTIMICROBIAL N-CHLORINATED COMPOSITIONS | NOVABAY PHARMACEUTICALS, INC. | 2010-06-24 | — | — | US | disclosed |
| US-20100158818-A1 | ANTIMICROBIAL N-CHLORINATED COMPOSITIONS | NOVABAY PHARMACEUTICALS, INC. | 2010-06-24 | — | — | US | disclosed |
| US-20070203125-A1 | Medicament Combinations for the Treatment of Respiratory Diseases | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2007-08-30 | — | — | US | disclosed |
| US-7148371-B2 | Method for producing lysine derivative | AJINOMOTO CO., INC. (JP) | 2006-12-12 | — | — | US | disclosed |
| US-20060063817-A1 | New betamimetics for the treatment of respiratory complaints | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2006-03-23 | — | — | US | disclosed |
| US-7012152-B2 | Method for producing lysine derivative | AJINOMOTO CO., INC. (JP) | 2006-03-14 | — | — | US | disclosed |
| US-20060004103-A1 | Method for producing lysine derivative | AJINOMOTO CO., INC. (JP) | 2006-01-05 | — | — | US | disclosed |
| US-20040054216-A1 | Method for producing lysine derivative | AJINOMOTO CO., INC. (JP) | 2004-03-18 | — | — | US | disclosed |
| US-6664412-B2 | Protecting amino group or amino group and carboxyl group of optically active 2-amino-6-methyl-6-nitroheptanoic acid with protecting group, reducing nitro group to synthesize 6,6-dimethyllysine and reacting this with acetic acid | AJINOMOTO CO., INC. (JP) | 2003-12-16 | — | — | US | disclosed |
| US-20030105351-A1 | Method for producing lysine derivative | AJINOMOTO CO. INC (JP) | 2003-06-05 | — | — | US | disclosed |
| US-20020042537-A1 | Method for producing lysine derivative | AJINOMOTO CO., INC. (JP) | 2002-04-11 | — | — | US | disclosed |
| EP-1179599-A2 | Method for producing lysine derivative | Ajinomoto Co., Inc. (JP) | 2002-02-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060063817-A1 | New betamimetics for the treatment of respiratory complaints | CHRM1, ADRB1, ADRA1B | ALDH1A1 1726/4885L3MBTL1 1683/4885 |
| US-20030105351-A1 | Method for producing lysine derivative | JMJD6, SIRT6, KDM6A | ALDH1A1 553/4885L3MBTL1 1334/4885 |
| US-20040054216-A1 | Method for producing lysine derivative | JMJD6, SIRT6, KDM6A | ALDH1A1 553/4885L3MBTL1 1334/4885 |
| US-20250197420-A1 | MACROCYCLIC COMPOUNDS, COMPOSITIONS, AND METHODS OF USING THEREOF | CFTR, ABCB1, PKD1 | ALDH1A1 3545/4885L3MBTL1 4499/4885 |
| US-20020042537-A1 | Method for producing lysine derivative | JMJD6, SIRT6, KDM6A | ALDH1A1 553/4885L3MBTL1 1334/4885 |
| US-20100158818-A1 | ANTIMICROBIAL N-CHLORINATED COMPOSITIONS | NRDC, NHERF1, MPO | ALDH1A1 3343/4885L3MBTL1 3847/4885 |
| US-20070203125-A1 | Medicament Combinations for the Treatment of Respiratory Diseases | CHRM1, CHRM2, MTNR1B | ALDH1A1 993/4885L3MBTL1 2693/4885 |
| US-20100297028-A1 | MEDICAMENT COMBINATIONS FOR THE TREATMENT OF RESPIRATORY DISEASES | CHRM1, CHRM2, MTNR1B | ALDH1A1 993/4885L3MBTL1 2693/4885 |
| US-20060004103-A1 | Method for producing lysine derivative | JMJD6, SIRT6, KDM6A | ALDH1A1 553/4885L3MBTL1 1334/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.